Free Trial

Senseonics (SENS) Competitors

Senseonics logo
$0.49 +0.01 (+3.03%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$0.49 +0.00 (+0.82%)
As of 07:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SENS vs. TRNS, ALNT, EYPT, LAB, CTKB, AEHR, QSI, QTRX, MASS, and FEIM

Should you be buying Senseonics stock or one of its competitors? The main competitors of Senseonics include Transcat (TRNS), Allient (ALNT), Eyepoint Pharmaceuticals (EYPT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), Quantum-Si (QSI), Quanterix (QTRX), 908 Devices (MASS), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry.

Senseonics vs. Its Competitors

Transcat (NASDAQ:TRNS) and Senseonics (NYSE:SENS) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

98.3% of Transcat shares are owned by institutional investors. Comparatively, 12.4% of Senseonics shares are owned by institutional investors. 2.3% of Transcat shares are owned by insiders. Comparatively, 4.3% of Senseonics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Transcat had 8 more articles in the media than Senseonics. MarketBeat recorded 8 mentions for Transcat and 0 mentions for Senseonics. Transcat's average media sentiment score of 0.62 beat Senseonics' score of 0.00 indicating that Transcat is being referred to more favorably in the media.

Company Overall Sentiment
Transcat Positive
Senseonics Neutral

Transcat currently has a consensus price target of $114.00, indicating a potential upside of 28.31%. Senseonics has a consensus price target of $1.55, indicating a potential upside of 216.33%. Given Senseonics' stronger consensus rating and higher probable upside, analysts clearly believe Senseonics is more favorable than Transcat.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Transcat
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Senseonics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

Transcat has higher revenue and earnings than Senseonics. Senseonics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Transcat$278.42M2.97$14.52M$1.5656.96
Senseonics$23.68M13.54-$60.39M-$0.11-4.45

Transcat has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, Senseonics has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.

Transcat has a net margin of 5.21% compared to Senseonics' net margin of -362.30%. Transcat's return on equity of 6.47% beat Senseonics' return on equity.

Company Net Margins Return on Equity Return on Assets
Transcat5.21% 6.47% 5.02%
Senseonics -362.30%-842.25%-67.99%

Summary

Transcat beats Senseonics on 11 of the 17 factors compared between the two stocks.

Get Senseonics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SENS vs. The Competition

MetricSenseonicsProcess control instruments IndustryMedical SectorNYSE Exchange
Market Cap$320.57M$20.39B$5.54B$20.53B
Dividend YieldN/A0.58%5.39%3.77%
P/E Ratio-3.7719.7426.2327.85
Price / Sales13.547.32413.2337.49
Price / CashN/A22.2636.1321.91
Price / Book7.005.118.044.55
Net Income-$60.39M$495.21M$3.15B$984.95M
7 Day Performance-2.00%-0.93%1.44%2.31%
1 Month Performance-7.49%-3.91%3.62%4.85%
1 Year Performance25.06%13.03%34.68%13.81%

Senseonics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SENS
Senseonics
1.5499 of 5 stars
$0.49
+3.0%
$1.55
+216.3%
+24.7%$320.57M$23.68M-3.7790
TRNS
Transcat
2.9859 of 5 stars
$80.27
-0.3%
$114.00
+42.0%
-28.3%$748.12M$278.42M51.461,245
ALNT
Allient
2.3029 of 5 stars
$34.61
+2.6%
$31.00
-10.4%
+54.1%$585.95M$529.97M58.662,525
EYPT
Eyepoint Pharmaceuticals
2.4444 of 5 stars
$8.28
-1.7%
$25.67
+210.0%
+20.6%$569.75M$43.27M-3.44120
LAB
Standard BioTools
3.5357 of 5 stars
$1.23
+17.1%
$2.50
+103.3%
-22.6%$467.18M$174.43M-3.51620Positive News
High Trading Volume
CTKB
Cytek Biosciences
3.1944 of 5 stars
$3.12
+5.8%
$5.60
+79.5%
-35.5%$395.18M$200.45M-34.66500News Coverage
High Trading Volume
AEHR
Aehr Test Systems
4.0515 of 5 stars
$11.25
+0.9%
$25.00
+122.2%
+41.3%$334.91M$66.22M14.4290Gap Up
QSI
Quantum-Si
2.4511 of 5 stars
$1.65
-4.6%
$3.48
+110.6%
+108.0%$302.78M$3.06M-2.43150
QTRX
Quanterix
2.8654 of 5 stars
$6.30
+2.9%
$15.60
+147.6%
-45.6%$244.63M$137.42M-4.85460
MASS
908 Devices
1.7027 of 5 stars
$6.64
-9.5%
$5.33
-19.7%
+39.7%$238.11M$59.63M-12.3060
FEIM
Frequency Electronics
2.5401 of 5 stars
$23.24
+9.5%
N/A+137.4%$224.96M$55.27M9.64200High Trading Volume

Related Companies and Tools


This page (NYSE:SENS) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners